PUBLIC COMPANY
saveFRESENIUS
USupdated 3mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- WuXi Biologics, Fresenius partner ahead of biosimilar boomWuXi Biologics and German drugmaker Fresenius have reached one of the largest biosimilar deals to date ahead of what some in the industry have called an upcoming “golden decade” for such products. ...endpoints · 11h ago
- Robotics company Multiply Labs nets $75M; Isotope maker NorthStar gets up to $185MPlus, news about Roche’s Genentech and Fresenius Kabi. Multiply Labs collects $75M: The robotics biomanufacturing company’s Series B raise will be used to increase its capacity and headcount as it…endpoints · 25d ago
- Viatris boosts pain drug portfolio with $1.7B buyout of PaciraThe deal hands Viatris two non-opioid pain treatments that booked nearly $700 million in 2025 but could soon lose patent protection. Viatris vowed to use its “intellectual property expertise” to su…biopharma_dive · 25d ago
- Fresenius Kabi manufacturing plant hit with FDA warning letter after adverse eventsPatients had adverse events after receiving a Fresenius Kabi medicine that experienced manufacturing deviations.biospace · 1mo ago
- After GLP-1s, biosimilars are the new frontier in direct-to-employer plansFresenius Kabi will sell biosimilars directly to employers. To accomplish that, the drugmaker is working with Eversana-owned Waltz Health, which runs a marketplace that helps employers shop for bet…endpoints · 1mo ago
- Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass ParticlesFOR IMMEDIATE RELEASE – August 10, 2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (…fda_medwatch · 2mo ago
- Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-upFOR IMMEDIATE RELEASE – 8/4/2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist® 2 mg…fda_medwatch · 3mo ago
- Infusion Pump Correction: Fresenius Kabi Issues Correction for dropped or jarred Ivenix Large Volume Infusion PumpsIf dropped, the Ivenix pump touchscreen may become unresponsive and should be removed from use.fda_medwatch · 3mo ago
- Infusion Pump Correction: Fresenius Kabi Issues Correction for Ivenix Large Volume Infusion PumpA software anomaly may cause a false battery-health value. The pump should remain plugged in at all times.fda_medwatch · 3mo ago
comments(0)
5-min edit window · permanent after that